0001179110-11-006775.txt : 20110421
0001179110-11-006775.hdr.sgml : 20110421
20110421181834
ACCESSION NUMBER: 0001179110-11-006775
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110419
FILED AS OF DATE: 20110421
DATE AS OF CHANGE: 20110421
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Thomas Helmut
CENTRAL INDEX KEY: 0001515616
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35119
FILM NUMBER: 11774384
MAIL ADDRESS:
STREET 1: 4819 EMPEROR BOULEVARD
STREET 2: SUITE 400
CITY: DURHAM
STATE: NC
ZIP: 27703
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TRANZYME INC
CENTRAL INDEX KEY: 0001274644
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 631192270
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4819 EMPEROR BOULEVARD, SUITE 400
CITY: DURHAM
STATE: NC
ZIP: 27703
BUSINESS PHONE: 919 313-4760
MAIL ADDRESS:
STREET 1: 4819 EMPEROR BOULEVARD, SUITE 400
CITY: DURHAM
STATE: NC
ZIP: 27703
4
1
edgar.xml
FORM 4 -
X0303
4
2011-04-19
0
0001274644
TRANZYME INC
TZYM
0001515616
Thomas Helmut
C/O TRANZYME, INC.
4819 EMPEROR BOULEVARD, SUITE 400
DURHAM
NC
27703
0
1
0
0
Senior VP, R&D
Stock Option (right to buy)
4.00
2011-04-19
4
A
0
78641
0
A
2021-04-19
Common Stock
78641
78641
D
25% of the shares will vest and become exercisable on April 19, 2012, with the remainder vesting and becoming exercisable in equal quarterly installments for the following 12 quarters thereafter.
/s/ Richard I. Eisenstadt, attorney-in-fact
2011-04-21